ACER logo

Acer Therapeutics (ACER) Operating Expenses

Annual Operating Expenses

$24.61 M
+$7.41 M+43.04%

December 31, 2022

Summary

Performance

1-Year Change

+43.04%

3-Year Change

-17.67%

5-Year Change

+76.47%

15-Year Change

+76.47%

ACER Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$29.90 M
ACER annual total operating expenses is currently -17.67% below its historical high of $29.90 million

3-Year Low

$17.21 M
ACER annual total operating expenses is currently +43.04% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ACER previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ACER next annual earnings announcement has not yet been scheduled

OtherACERexpensesmetrics:

Annual Total Expenses

$24.61 M
ACER annual total expenses is $24.61 million

Annual Interest Expense

-
ACER annual interest expense value is unknown

Annual Income Tax

-
ACER annual income tax value is unknown

Annual Cost Of Goods Sold

-
ACER annual cost of goods sold value is unknown

Quarterly Operating Expenses

$4.29 M
-$694.80 K-13.93%

June 30, 2023

Summary

Performance

3-Month Change

-13.93%

1-Year Change

-39.21%

3-Year Change

-25.57%

5-Year Change

-12.64%

ACER Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.17 M
ACER quarterly total operating expenses is currently -61.54% below its historical high of $11.17 million

3-Year Low

$4.29 M
ACER quarterly total operating expenses is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ACER previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ACER next earnings announcement has not yet been scheduled

OtherACERexpensesmetrics:

Quarterly Total Expenses

$4.29 M
ACER quarterly total expenses is $4.29 million

Quarterly Interest Expense

-
ACER quarterly interest expense value is unknown

Quarterly Income Tax

-
ACER quarterly income tax value is unknown

Quarterly Cost Of Goods Sold

-
ACER quarterly cost of goods sold value is unknown

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$24.61 M
ACER annual total operating expenses is $24.61 million

Annual SGA

$12.69 M
ACER annual SGA is $12.69 million

Annual D&A

$66.00 K
ACER annual depreciation & amortization is $66.00 thousand

ACER Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+43.0%-39.2%
3 y3 years-17.7%-25.6%
5 y5 years+76.5%-12.6%

ACER Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-30.1%-39.2%at low
5 y5-year-17.7%-30.1%-39.2%-23.7%
alltimeall time-17.7%-99.5%-61.5%-99.5%

Acer Therapeutics Operating Expenses History

DateAnnualQuarterly
Jun 2023
-
$4.29 M(-13.9%)
Mar 2023
-
$4.99 M(-5.2%)
Dec 2022
$24.61 M(+43.0%)
$5.26 M(+0.5%)
Sep 2022
-
$5.24 M(-25.8%)
Jun 2022
-
$7.06 M(+0.2%)
Mar 2022
-
$7.05 M(+47.4%)
Dec 2021
$17.21 M(-24.5%)
$4.78 M(+45.8%)
Sep 2021
-
$3.28 M(-9.7%)
Jun 2021
-
$3.63 M(-34.2%)
Mar 2021
-
$5.52 M(-10.6%)
Dec 2020
$22.80 M(-23.7%)
$6.17 M(+4.8%)
Sep 2020
-
$5.89 M(+2.1%)
Jun 2020
-
$5.77 M(+16.1%)
Mar 2020
-
$4.97 M(-4.3%)
Dec 2019
$29.90 M(+37.7%)
$5.19 M(-3.2%)
Sep 2019
-
$5.36 M(-52.0%)
Jun 2019
-
$11.17 M(+36.6%)
Mar 2019
-
$8.18 M(-6.0%)
Dec 2018
$21.71 M(+55.7%)
$8.70 M(+111.8%)
Sep 2018
-
$4.11 M(-16.5%)
Jun 2018
-
$4.92 M(+23.2%)
Mar 2018
-
$3.99 M(-5.1%)
Dec 2017
$13.95 M(+41.5%)
$4.21 M(+25.2%)
Sep 2017
-
$3.36 M(+395.6%)
Jun 2017
-
$677.90 K(-26.8%)
Mar 2017
-
$925.90 K(-34.1%)
Dec 2016
$9.86 M(-32.7%)
$1.40 M(-48.6%)
Sep 2016
-
$2.73 M(-3.7%)
Jun 2016
-
$2.83 M(-1.9%)
Mar 2016
-
$2.89 M(-8.0%)
Dec 2015
$14.65 M(-10.3%)
$3.14 M(-11.1%)
Sep 2015
-
$3.53 M(-16.6%)
Jun 2015
-
$4.24 M(+13.2%)
Mar 2015
-
$3.74 M(+2.0%)
Dec 2014
$16.34 M(+23.9%)
$3.67 M(-12.5%)
Sep 2014
-
$4.19 M(-6.4%)
Jun 2014
-
$4.48 M(+11.6%)
Mar 2014
-
$4.01 M(-2.5%)
Dec 2013
$13.19 M(+44.4%)
$4.11 M(+28.0%)
Sep 2013
-
$3.21 M(+4.9%)
Jun 2013
-
$3.06 M(+9.3%)
Mar 2013
-
$2.80 M(+11.1%)
Dec 2012
$9.13 M(+53.3%)
$2.52 M(+21.9%)
Sep 2012
-
$2.07 M(-4.4%)
Jun 2012
-
$2.16 M(-8.8%)
Mar 2012
-
$2.37 M(+27.1%)
Dec 2011
$5.96 M
$1.87 M(+44.0%)
Sep 2011
-
$1.30 M(-12.7%)
Jun 2011
-
$1.49 M(+13.7%)
DateAnnualQuarterly
Mar 2011
-
$1.31 M(+40.0%)
Dec 2010
$4.97 M(+14.4%)
$933.60 K(-27.6%)
Sep 2010
-
$1.29 M(-9.8%)
Jun 2010
-
$1.43 M(+8.5%)
Mar 2010
-
$1.32 M(+25.2%)
Dec 2009
$4.34 M(-63.7%)
$1.05 M(-13.0%)
Sep 2009
-
$1.21 M(+35.8%)
Jun 2009
-
$891.10 K(-25.2%)
Mar 2009
-
$1.19 M(-40.1%)
Dec 2008
$11.97 M(-28.5%)
$1.99 M(-36.9%)
Sep 2008
-
$3.15 M(-14.6%)
Jun 2008
-
$3.69 M(+17.4%)
Mar 2008
-
$3.14 M(-19.0%)
Dec 2007
$16.74 M(+24.1%)
$3.88 M(-5.0%)
Sep 2007
-
$4.08 M(-11.9%)
Jun 2007
-
$4.63 M(+1.6%)
Mar 2007
-
$4.56 M(+122.7%)
Dec 2006
$13.49 M(+16.9%)
$2.05 M(-48.9%)
Sep 2006
-
$4.01 M(-22.7%)
Jun 2006
-
$5.19 M(+130.8%)
Mar 2006
-
$2.25 M(-12.5%)
Dec 2005
$11.54 M(+206.9%)
$2.57 M(-24.1%)
Sep 2005
-
$3.39 M(+2.1%)
Jun 2005
-
$3.32 M(+46.1%)
Mar 2005
-
$2.27 M(+9.4%)
Dec 2004
$3.76 M(+2987.1%)
$2.07 M(+238.9%)
Sep 2004
-
$612.10 K(+18.6%)
Jun 2004
-
$516.20 K(+2050.8%)
Mar 2004
-
$24.00 K(-6.6%)
Dec 2003
-
$25.70 K(-3.7%)
Sep 2003
$121.80 K(-24.0%)
-
Jun 2003
-
$26.70 K(-21.5%)
Mar 2003
-
$34.00 K(+1.5%)
Dec 2002
-
$33.50 K(+48.9%)
Sep 2002
$160.30 K(-69.7%)
$22.50 K(-39.4%)
Jun 2002
-
$37.10 K(-17.4%)
Mar 2002
-
$44.90 K(-19.5%)
Dec 2001
-
$55.80 K(-67.9%)
Sep 2001
$528.30 K(-45.8%)
$173.90 K(+80.0%)
Jun 2001
-
$96.60 K(+57.6%)
Mar 2001
-
$61.30 K(-68.8%)
Dec 2000
-
$196.60 K(-48.8%)
Sep 2000
$975.60 K(+33.6%)
$383.90 K(+64.8%)
Jun 2000
-
$232.90 K(+14.8%)
Mar 2000
-
$202.90 K(+30.1%)
Dec 1999
-
$155.90 K(-11.4%)
Sep 1999
$730.50 K
$176.00 K(-6.9%)
Jun 1999
-
$189.10 K(+1.9%)
Mar 1999
-
$185.50 K(+4.7%)
Dec 1998
-
$177.20 K

FAQ

  • What is Acer Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Acer Therapeutics?
  • What is Acer Therapeutics annual operating expenses year-on-year change?
  • What is Acer Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Acer Therapeutics?
  • What is Acer Therapeutics quarterly operating expenses year-on-year change?

What is Acer Therapeutics annual total operating expenses?

The current annual operating expenses of ACER is $24.61 M

What is the all time high annual operating expenses for Acer Therapeutics?

Acer Therapeutics all-time high annual total operating expenses is $29.90 M

What is Acer Therapeutics annual operating expenses year-on-year change?

Over the past year, ACER annual total operating expenses has changed by +$7.41 M (+43.04%)

What is Acer Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of ACER is $4.29 M

What is the all time high quarterly operating expenses for Acer Therapeutics?

Acer Therapeutics all-time high quarterly total operating expenses is $11.17 M

What is Acer Therapeutics quarterly operating expenses year-on-year change?

Over the past year, ACER quarterly total operating expenses has changed by -$2.77 M (-39.21%)